Related Experiment Video
Updated: Aug 15, 2026

Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)
Published on: September 11, 2012
Decrease in size of azoxymethane induced colon carcinoma in F344 rats by 180-day fermented miso
Yoshie Ohuchi1, Yuki Myojin, Fumio Shimamoto
1Department of Health Science, Hiroshima Prefectural Women's University, 1-1-71 Ujina-higashi, Minami-ku, Hiroshima 734-8558, Japan.
Abstract:
The present study was designed to investigate the effects of fermented miso (fermented soybean paste) on the induction of colon tumors by azoxymethane (AOM) in male F344 rats. A total of 91 rats, 6 weeks of age, were divided into 5 groups and given weekly subcutaneous injections of AOM (15 mg/kg body wt) for 3 weeks. The animals were placed on diets one week before the first AOM dose: commercial normal control MF diet or a diet containing 10% 2-year, 180-day fermented, or 3-4-day fermented miso. There were no differences in body and organ weights, and no aberrant crypt foci (ACF) among carcinogen-treated groups at week 25. The rates of tumor incidence were 45%, 85%, 75% and 60% with the 2-year, 180-day, and 3-4-day fermented miso and MF, respectively, and those for colon tumors were 34%, 55%, 60% and 55%, respectively. The size of well-differentiated adenocarcinomas and total (well differentiated and signet ring cell) adenocarcinomas in the 180-day fermented miso group was significantly smaller than that in the 2-year fermented miso and MF+AOM groups. Nuclear staining of beta-catenin in colon tumors was increased for the 3-4-day fermented miso compared to the 180-day fermented miso. Cdx2 staining tendency was decreased in colon tumors and adenocarcinomas compared to normal mucosa and ACF, which stained in 100% of cases. In addition, the PCNA index was significantly reduced in the 180-day group compared with those groups receiving the 3-4-day fermented miso and MF diet. The germinal region was also decreased. The present results indicate that dietary supplementation with 180-day fermented dietary miso could act as a chemopreventive agent for colon carcinogenesis.
Insights
Fermented miso, a soybean paste, showed potential in preventing colon cancer in rats. A 180-day fermented miso diet reduced tumor size and proliferation markers, suggesting chemopreventive effects against azoxymethane-induced colon tumors.
Area of Science:
- Gastroenterology
- Oncology
- Nutritional Science
Background:
- Colorectal cancer remains a significant health concern globally.
- Dietary factors play a crucial role in cancer development and prevention.
- Fermented foods, like miso, are explored for their potential health benefits.
Purpose of the Study:
- To investigate the chemopreventive effects of fermented miso on azoxymethane (AOM)-induced colon carcinogenesis in male F344 rats.
- To evaluate the impact of different fermentation durations of miso on colon tumor development.
- To assess specific biomarkers related to colon cancer progression and proliferation.
Main Methods:
- Male F344 rats were administered AOM to induce colon tumors.
- Rats were fed diets containing different durations of fermented miso (3-4 days, 180 days, 2 years) or a control diet.
- Tumor incidence, size, aberrant crypt foci (ACF), and biomarkers (beta-catenin, Cdx2, PCNA) were analyzed.
Main Results:
- Dietary 180-day fermented miso significantly reduced the size of adenocarcinomas compared to control and 2-year fermented miso groups.
- The 180-day fermented miso group showed a reduced proliferation index (PCNA) and germinal region.
- Tumor incidence rates varied, with 180-day fermented miso showing a 55% colon tumor rate, comparable to the control.
Conclusions:
- Dietary supplementation with 180-day fermented miso demonstrated chemopreventive properties against colon carcinogenesis in a rat model.
- Miso fermentation duration influences its potential anti-cancer effects.
- Further research is warranted to elucidate the mechanisms and confirm these findings in human studies.
